<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00126 Mid Day Module (Pyqs, Mixed Bag-23) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">40</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 54831,
    "choices": [
      {
        "id": 218785,
        "text": "<p><span style=\"font-size:12.0pt;\">Varicose vein</span></p>"
      },
      {
        "id": 218786,
        "text": "<p><span style=\"font-size:12.0pt;\">Aneurysm</span></p>"
      },
      {
        "id": 218787,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemangioma</span></p>"
      },
      {
        "id": 218788,
        "text": "<p><span style=\"font-size:12.0pt;\">AV fistula</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presented to OPD with dilated tortuous veins in the leg. He had a history of trauma 10 years back in the same limb. On examination, the dilated tortuous vein showed pulsatility. Most likely diagnosis in this patient will be?&nbsp;(FMGE JULY 2024)</span></p>",
    "unique_key": "Q9204746",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855832,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) AV fistula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An arteriovenous (AV) fistula is an abnormal connection between an artery and a vein. The history of trauma in the same limb suggests a possible traumatic AV fistula. The presence of pulsatility in the veins is a key indicator, as it implies that arterial pressure is being transmitted to the veins. This is not typical for varicose veins, aneurysms, or hemangiomas, making AV fistula the most likely diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Varicose vein:</strong> Varicose veins are typically dilated, tortuous veins caused by incompetent valves but do not show pulsatility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aneurysm:</strong> Aneurysms involve arterial dilation and do not present with pulsatile veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hemangioma:</strong> Hemangiomas are benign tumors of blood vessels, usually presenting as a mass and not associated with pulsatile veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A history of trauma with the presence of dilated tortuous veins showing pulsatility strongly indicates an arteriovenous fistula due to the transmission of arterial pulsation to the veins</span></p>",
    "correct_choice_id": 218788,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50164,
    "choices": [
      {
        "id": 200215,
        "text": "<p><span style=\"font-size:12.0pt;\">Type I</span></p>"
      },
      {
        "id": 200216,
        "text": "<p><span style=\"font-size:12.0pt;\">Type II</span></p>"
      },
      {
        "id": 200217,
        "text": "<p><span style=\"font-size:12.0pt;\">Type III</span></p>"
      },
      {
        "id": 200218,
        "text": "<p><span style=\"font-size:12.0pt;\">Type IV</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Type 2 lepra reaction is which type of hypersensitivity reaction? (</span>FMGE July 2023)</p>",
    "unique_key": "Q2745003",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855836,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Type III</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Type 2 lepra reaction (also known as erythema nodosum leprosum, ENL) is mediated by a Type III hypersensitivity reaction. In this type of reaction:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Immune complexes (antigen-antibody complexes) deposit in tissues, leading to complement activation and inflammation.</span></li><li><span style=\"font-size:12.0pt;\">This reaction occurs in lepromatous leprosy due to a sudden increase in circulating Mycobacterium leprae antigens that form immune complexes with antibodies.</span></li><li><span style=\"font-size:12.0pt;\">The immune complexes cause tissue damage, resulting in tender erythematous nodules, fever, and systemic inflammation.</span></li><li><span style=\"font-size:12.0pt;\">Key Features of Type III Hypersensitivity:</span></li><li><span style=\"font-size:12.0pt;\">Immune complex-mediated (IgG or IgM antibodies bind to soluble antigens).</span></li><li><span style=\"font-size:12.0pt;\">Complement activation and neutrophilic inflammation.</span></li><li><span style=\"font-size:12.0pt;\">Examples: Type 2 lepra reaction, serum sickness, systemic lupus erythematosus (SLE), post-streptococcal glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A) Type I Hypersensitivity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mediated by IgE antibodies, causing mast cell degranulation.</span></li><li><span style=\"font-size:12.0pt;\">Seen in allergic reactions, anaphylaxis, and atopic conditions (e.g., urticaria, asthma).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B) Type II Hypersensitivity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Involves cytotoxic antibodies (IgG or IgM) binding to cell-bound antigens, leading to cell destruction via complement or ADCC (antibody-dependent cellular cytotoxicity).</span></li><li><span style=\"font-size:12.0pt;\">Examples: Hemolytic anemia, Goodpasture syndrome, Rh incompatibility.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D) Type IV Hypersensitivity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cell-mediated immunity involving T-lymphocytes and macrophages.</span></li><li><span style=\"font-size:12.0pt;\">Delayed onset (48-72 hours) and seen in tuberculin skin tests, contact dermatitis, and granuloma formation.</span></li><li><span style=\"font-size:12.0pt;\">Type I lepra reaction (reversal reaction) is an example of Type IV hypersensitivity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Type 2 lepra reaction (erythema nodosum leprosum) is a Type III hypersensitivity reaction caused by immune complex deposition. It presents with tender nodules, fever, and systemic inflammation and is commonly associated with lepromatous leprosy.</span></p>",
    "correct_choice_id": 200217,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55492,
    "choices": [
      {
        "id": 221425,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct association</span></span></span></p>"
      },
      {
        "id": 221426,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indirect association</span></span></span></p>"
      },
      {
        "id": 221427,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spurious association</span></span></span></p>"
      },
      {
        "id": 221428,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">No association</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A gymnasium owner found that people drank ice tea while exercising in his gym. He further mentioned that the subsequent weight loss was solely due to ice tea. This is a type of: (FMGE JULY 2024)</span></span></span></p>",
    "unique_key": "Q9988825",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855845,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Spurious association</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A spurious association occurs when a relationship between two variables is falsely inferred, often due to the presence of a confounding variable. In this case, the gym owner observed that people drank ice tea while exercising and then experienced weight loss. However, the weight loss is actually due to the exercise, not the ice tea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The gym owner incorrectly attributed the weight loss solely to the consumption of ice tea, which is a classic example of a spurious association&mdash;where the real cause (exercise) is overlooked or ignored, and an unrelated factor (ice tea) is wrongly identified as the cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Direct association:</span></strong><span style=\"font-size:12.0pt\"> This would imply a straightforward cause-and-effect relationship; such as exercise leading directly to weight loss. This is not applicable here because the claim was that ice tea, not exercise, caused the weight loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Indirect association:</span></strong><span style=\"font-size:12.0pt\"> An indirect association occurs when the relationship between two variables is mediated by one or more additional variables. For example, exercise might lead to increased metabolism, which in turn leads to weight loss. This is not applicable in this scenario because the weight loss is directly due to exercise, not mediated by another factor like ice tea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. No association:</span></strong><span style=\"font-size:12.0pt\"> This would imply that there is no relationship at all between the variables. However, in this scenario, the gym owner has incorrectly claimed an association, which makes it a spurious association rather than no association.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A spurious association occurs when a relationship is wrongly inferred between two variables due to a confounding factor. In this case, the gym owner incorrectly attributed weight loss to ice tea consumption rather than the true cause, which is exercise.</span></span></span></p>",
    "correct_choice_id": 221427,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 46010,
    "choices": [
      {
        "id": 183663,
        "text": "<p><span style=\"font-size:12.0pt;\">Thalamus</span></p>"
      },
      {
        "id": 183664,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypothalamus</span></p>"
      },
      {
        "id": 183665,
        "text": "<p><span style=\"font-size:12.0pt;\">Amygdala</span></p>"
      },
      {
        "id": 183666,
        "text": "<p><span style=\"font-size:12.0pt;\">Caudate nuclei</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A man eats 3 cones of ice cream. After some time, he starts feeling more colder ears than the central parts of his body. Which part of the brain is responsible for thermo-regulation?&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q3140516",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855848,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hypothalamus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hypothalamus is responsible for regulating body temperature, among other vital functions. It serves as the body's thermostat, receiving input from temperature receptors in the body and initiating appropriate responses to maintain homeostasis. When the body temperature deviates from the set point, the hypothalamus triggers mechanisms to adjust the temperature. For instance, if the body is too cold, the hypothalamus may initiate heat production processes such as shivering.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the scenario described, the man starts feeling colder in his ears compared to the central parts of his body. This is because the hypothalamus is actively managing the body's response to the cold stimuli (the ice cream), directing blood flow to the core to maintain essential organ temperature, which can result in peripheral parts like the ears feeling colder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. Thalamus: </strong>The thalamus is primarily involved in relaying sensory and motor signals to the cerebral cortex and regulating consciousness, sleep, and alertness. It does not play a direct role in thermoregulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. Amygdala:</strong> The amygdala is involved in emotional processing, including fear and pleasure responses, and memory formation, but it does not regulate body temperature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Caudate nuclei</strong>: The caudate nuclei are part of the basal ganglia and are involved in various functions such as motor control and learning, but they are not involved in thermoregulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hypothalamus is the part of the brain responsible for regulating body temperature and maintaining homeostasis.</span></p>",
    "correct_choice_id": 183664,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10445,
    "choices": [
      {
        "id": 41746,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intermediate filaments</span></span></span></p>"
      },
      {
        "id": 41747,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Actin</span></span></span></p>"
      },
      {
        "id": 41748,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microtubules</span></span></span></p>"
      },
      {
        "id": 41749,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibronectin</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A chronic alcoholic patient presented with increasing abdominal girth. On examination, shifting dullness was present and the liver span was less than 7cm. Histopathological examination revealed the presence of intracytoplasmic eosinophilic inclusions in hepatocytes. What is the content of these inclusions? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q7557149",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855828,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Intermediate filaments </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical scenario given here describes alcoholic hepatitis. In this condition, there are intracytoplasmic eosinophilic inclusions called <strong>Mallory Denk bodies</strong> and they contain intermediate filaments.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">i) Hepatocellular necrosis: </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ii) Mallory bodies or alcoholic hyaline: </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These are eosinophilic, intracytoplasmic inclusions found in swollen and ballooned hepatocytes. They represent aggregates of cytoskeletal intermediate filaments (prekeratin). They are best seen with connective tissue stains such as Masson&#39;s trichrome and chromophobe aniline blue, as well as immunoperoxidase methods.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mallory bodies are highly suggestive of, but not specific for, alcoholic hepatitis, as they can be found in a variety of other conditions, including primary biliary cirrhosis, Indian childhood cirrhosis, cholestatic syndromes, Wilson&#39;s disease, intestinal bypass surgery, focal nodular hyperplasia, and hepatocellular carcinoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">iii) Inflammatory response: primarily polymorphs with some scattered mononuclear cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">iv) Fibrosis: Pericellular and perivenular fibrosis that appears web-like or chickenwire-like. This is also termed as <strong>creeping&nbsp;</strong></span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>collagenosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Actin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Actin is a type of microfilament found in the cytoskeleton of cells, but it is not the primary component of Mallory-Denk bodies.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Microtubules:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Microtubules are another component of the cytoskeleton, but they are not the primary component of Mallory-Denk bodies.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp; D. Fibronectin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Fibronectin is a high-molecular-weight glycoprotein of the extracellular matrix that binds to membrane-spanning receptor proteins such as integrins. It is not a component of Mallory-Denk bodies.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In chronic alcoholic patients with alcoholic hepatitis, Mallory-Denk bodies are a characteristic histopathological finding. These intracytoplasmic eosinophilic inclusions consist of aggregated cytoskeletal intermediate filaments, specifically prekeratin.</span></span></span></p>",
    "correct_choice_id": 41746,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 45983,
    "choices": [
      {
        "id": 183555,
        "text": "<p><span style=\"font-size:12.0pt;\">Forced vital capacity</span></p>"
      },
      {
        "id": 183556,
        "text": "<p><span style=\"font-size:12.0pt;\">Expiratory reserve volume</span></p>"
      },
      {
        "id": 183557,
        "text": "<p><span style=\"font-size:12.0pt;\">Total lung capacity</span></p>"
      },
      {
        "id": 183558,
        "text": "<p><span style=\"font-size:12.0pt;\">Inspiratory capacity</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In the presented spirometry image, what term corresponds to the point labelled as 'F'?&nbsp;</span>(FMGE Jan 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/1.jpg\" alt=\"\" width=\"400\" height=\"168\"></p>",
    "unique_key": "Q3023220",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855817,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Forced vital capacity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The spirometry diagram illustrates various lung volumes and capacities \u2013</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The point labelled 'F' corresponds to the forced vital capacity (FVC), which is the maximum amount of air a person can forcibly exhale from their lungs after taking the deepest breath possible. It includes the tidal volume (TV), inspiratory reserve volume (IRV), and expiratory reserve volume (ERV).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In this context:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tidal Volume (TV): The amount of air inhaled or exhaled during normal breathing (A).</span></li><li><span style=\"font-size:12.0pt;\">Inspiratory Reserve Volume (IRV): The additional air that can be inhaled after a normal inhalation (B).</span></li><li><span style=\"font-size:12.0pt;\">Expiratory Reserve Volume (ERV): The additional air that can be exhaled after a normal exhalation (C).</span></li><li><span style=\"font-size:12.0pt;\">Forced Vital Capacity (FVC): The total volume of air that can be exhaled forcefully after taking a deep breath (TV + IRV + ERV) (F).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Expiratory reserve volume:&nbsp;</strong>This is the additional volume of air that can be forcibly exhaled after normal exhalation, represented by 'C' in the diagram.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Total lung capacity:&nbsp;</strong>This is the total volume of air in the lungs after a maximum inhalation, including the residual volume. It is not represented by 'F'.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inspiratory capacity:&nbsp;</strong>This is the total volume of air that can be inhaled after a normal exhalation, represented by 'D' in the diagram.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Spirometry diagram</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/4-physiology-fmge-2.jpg\" alt=\"\" width=\"700\" height=\"241\"></p>",
    "correct_choice_id": 183555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "ImageBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55462,
    "choices": [
      {
        "id": 221309,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgA vasculitis</span></span></p>"
      },
      {
        "id": 221310,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulomatosis with polyangiitis</span></span></p>"
      },
      {
        "id": 221311,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Microscopic polyangiitis</span></span></p>"
      },
      {
        "id": 221312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Beh&ccedil;et&#39;s disease</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">15-year-old patient presents with abdominal pain, joint pain, and palpable purpura. CRP<strong> </strong>and ESR were elevated, and urinalysis showed RBCs. What is the diagnosis? (FMGE JULY 2024)</span></span></p>",
    "unique_key": "Q3359948",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855818,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) IgA vasculitis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgA vasculitis, formerly known as Henoch-Sch&ouml;nlein purpura (HSP), is a small-vessel vasculitis characterized by the deposition of IgA immune complexes. It commonly presents in children and young adults with a classic tetrad of symptoms: palpable purpura, abdominal pain, arthritis or arthralgia, and renal involvement (hematuria). The elevated CRP and ESR indicate an inflammatory process, and the presence of RBCs in the urine suggests renal involvement, all of which are consistent with IgA vasculitis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Granulomatosis with polyangiitis:</strong> This condition, formerly known as Wegener&#39;s granulomatosis, is a type of vasculitis affecting small to medium-sized vessels and is characterized by granulomas, often affecting the respiratory tract and kidneys. It does not typically present with palpable purpura.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Microscopic polyangiitis:</strong> This is another small-vessel vasculitis that can present with renal involvement and systemic symptoms, but it does not typically present with palpable purpura and is not specifically associated with IgA deposition.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Beh&ccedil;et&#39;s disease:</strong> Beh&ccedil;et&#39;s disease is a vasculitis that can affect vessels of all sizes and presents with recurrent oral and genital ulcers, uveitis, and skin lesions. Palpable purpura and the specific symptom triad in this case are not characteristic of Beh&ccedil;et&#39;s disease.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgA vasculitis (Henoch-Sch&ouml;nlein purpura) commonly presents with palpable purpura, abdominal pain, joint pain, and renal involvement, and is characterized by IgA immune complex deposition.</span></span></p>",
    "correct_choice_id": 221309,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13013,
    "choices": [
      {
        "id": 52014,
        "text": "<p><span style=\"font-size:12.0pt;\">2,3,4,5</span></p>"
      },
      {
        "id": 52015,
        "text": "<p><span style=\"font-size:12.0pt;\">4,5,6</span></p>"
      },
      {
        "id": 52016,
        "text": "<p><span style=\"font-size:12.0pt;\">Only 5</span></p>"
      },
      {
        "id": 52017,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the features given below is of a male pelvis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Triangular obturator foramen</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">U-shaped pubic angle</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Everted ischial tuberosity</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Large greater sciatic notch</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Large acetabulum</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Deep preauricular sulcus</span></p></li></ol>",
    "unique_key": "Q9430881",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855821,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C. Only 5&nbsp;&nbsp;</strong>&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Large acetabulum:&nbsp;</strong>The acetabulum in males is generally larger to support a greater range of motion and the weight of a more muscular body.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Features:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Triangular obturator foramen:&nbsp;</strong>Typically seen in males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. U-shaped pubic angle:&nbsp;</strong>This is more characteristic of the female pelvis, which has a wider pubic angle to facilitate childbirth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Everted ischial tuberosity:&nbsp;</strong>This is more common in females.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Large greater sciatic notch:&nbsp;</strong>More pronounced in females.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>6. Deep preauricular sulcus:&nbsp;</strong>More commonly seen in females.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Differences between male and female pelvis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-30.jpg\" alt=\"\" width=\"500\" height=\"269\"></span></p>",
    "correct_choice_id": 52016,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5172,
    "choices": [
      {
        "id": 20661,
        "text": "<p><span style=\"font-size:12.0pt;\">Chevallet and Jarjaway fracture</span></p>"
      },
      {
        "id": 20662,
        "text": "<p><span style=\"font-size:12.0pt;\">Citelli fracture</span></p>"
      },
      {
        "id": 20663,
        "text": "<p><span style=\"font-size:12.0pt;\">Tripod fracture</span></p>"
      },
      {
        "id": 20664,
        "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The vertical and horizontal fracture of nasal septum is: (NEET PG 2018)</span></p>",
    "unique_key": "Q9293463",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855820,
    "difficulty_level": "beginner",
    "subjects_id": [
      9
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chevallet and Jarjaway fracture</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Chevallet fracture</strong> - Fracture line runs vertically from the anterior nasal spine upwards to the junction of the bony and cartilaginous dorsum of the nose.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/5_fBBc4Yc.jpg\" alt=\"\" width=\"500\" height=\"382\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Jarjaway fracture</strong> - Fracture line starts just above the anterior nasal spine and runs horizontally backward just above the junction of septal cartilage with the vomer.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/6_XzGK6Dm.jpg\" alt=\"\" width=\"500\" height=\"387\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tripod fracture </strong>\u2013 is zygomatic fracture. Zygoma is separated into three processes. Fracture line passes through zygomaticofrontal suture, orbital floor, infraorbital margin and foramen, anterior wall of maxillary sinus and the zygomaticotemporal suture</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/7_8CGgvXW.jpg\" alt=\"\" width=\"500\" height=\"580\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Citelli fracture</strong> - This does not pertain to the nasal septum but rather involves other cranial structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tripod fracture</strong> - This is a zygomatic fracture where the zygoma is separated into three processes. The fracture line passes through the zygomaticofrontal suture, orbital floor, infraorbital margin and foramen, anterior wall of the maxillary sinus, and the zygomaticotemporal suture, unrelated to the nasal septum fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The Chevallet and Jarjaway fractures are important classifications in the context of nasal injuries, describing vertical and horizontal fractures of the nasal septum respectively. Understanding these fracture types aids in accurate diagnosis and management of nasal trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 166</strong></span></p>",
    "correct_choice_id": 20661,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11799,
    "choices": [
      {
        "id": 47162,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral sumatriptan</span></span></p>"
      },
      {
        "id": 47163,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subcutaneous sumatriptan</span></span></p>"
      },
      {
        "id": 47164,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 6 L/minute</span></span></p>"
      },
      {
        "id": 47165,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 8 L/minute</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment of choice for an acute attack of cluster headache is: (INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q3285611",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855847,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subcutaneous sumatriptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Subcutaneous sumatriptan is shown to be effective in treating acute attacks of cluster headaches. The reference indicates that oral sumatriptan is not effective, whereas subcutaneous sumatriptan has been proven beneficial. I</span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">ntranasal&nbsp;sumatriptan and intranasal zolmitriptan also are shown to be effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, 100% oxygen therapy at a rate of at least 12 liters per minute is effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral sumatriptan:</span></strong><span style=\"font-size:12.0pt\"> Oral sumatriptan has not been shown to be effective in treating acute cluster headache attacks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 100% oxygen at 6 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Although 100% oxygen is a treatment option, the effective rate is at least 12 liters per minute, making 6 L/minute inadequate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 100% oxygen at 8 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Similar to the previous option, 8 L/minute is below the effective rate of 12 liters per minute required for treating acute cluster headaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for an acute attack of cluster headache is subcutaneous sumatriptan, and 100% oxygen therapy should be administered at a rate of at least 12 liters per minute for effectiveness.</span></span></span></p>",
    "correct_choice_id": 47163,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10052,
    "choices": [
      {
        "id": 40174,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trichodysplasia spinulosa</span></span></span></p>"
      },
      {
        "id": 40175,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Condyloma accuminata</span></span></span></p>"
      },
      {
        "id": 40176,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum</span></span></span></p>"
      },
      {
        "id": 40177,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Donovanosis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents with lesions on the inner thighs and peri-anal region. They are nodular, 4-6 mm in size, and appear pale. The histopathological image shows multiple intracytoplasmic inclusion bodies consistent with Henderson-Patterson bodies. The diagnosis is: (INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture14.jpg\" style=\"height:265px; width:300px\" /></p>",
    "unique_key": "Q6364535",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855850,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;C) Molluscum contagiosum</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical history along with histological image showing <strong>intracytoplasmic inclusion bodies suggests a diagnosis of Molluscum contagiosum.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum <strong>is a poxvirus infection</strong> of the skin and the mucous membranes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There are four types of molluscum contagiosum viruses (MCVs), MCV-1 to -4, with <strong>MCV-1 being the most prevalent and MCV-2 being most often sexually transmitted. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The infections are common in young children between 2 and 12 years of age and are transmitted through direct contact or shared articles (e.g., towels). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum may affect any area of the skin but is most common on the trunk, arms, and legs. In adults, molluscum infections are typically sexually transmitted and affect the genitals, lower abdomen, buttocks, and inner thighs. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The average incubation period is 6 weeks. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis is based on the characteristic clinical appearance of pearly, <strong>domeshaped papules with a dimpled center</strong>. The papules measure 1 to 5 mm in diameter, and their central waxy core contains cells with intracytoplasmic viral inclusions called as <strong>Molluscum bodies or Henderson Patterson bodies.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture15.jpg\" style=\"height:122px; width:600px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Trichodysplasia spinulosa</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a rare viral infection associated with immunosuppression and does not typically present with the described clinical or histopathological features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Condyloma accuminata</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Caused by human papillomavirus (HPV), this condition presents as warty growths, typically on the genital and perianal regions, but it does not produce Henderson-Patterson bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Donovanosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Also known as granuloma inguinale, this sexually transmitted infection caused by <em>Klebsiella granulomatis</em> presents with ulcerative lesions rather than nodular papules and does not show the characteristic Henderson-Patterson bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a viral skin infection that presents with dome-shaped papules containing Henderson-Patterson bodies, which are diagnostic of this condition.</span></span></span></p>",
    "correct_choice_id": 40176,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7032,
    "choices": [
      {
        "id": 28096,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Topical mupirocin</span></p>"
      },
      {
        "id": 28097,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Oral Vancomycin</span></p>"
      },
      {
        "id": 28098,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Inhaled colistin</span></p>"
      },
      {
        "id": 28099,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">IV cefazolin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">There was outbreak of MRSA in the hospital, and it was found that a nurse of NICU had MRSA colonization of anterior nares. What is the best treatment?(INICET MAY 2024)</span><br>&nbsp;</p>",
    "unique_key": "Q2397479",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855816,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Topical mupirocin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Anterior nares are the most common site of colonization in carrier state of MRSA.</span></li><li><span style=\"color:#333333;font-size:12pt;\"><strong>Mupirocin (</strong>2% topical cream<strong>)&nbsp;</strong>is DOC for MRSA carriers. Other drug that can be used is topical Bacitracin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Oral Vancomycin:&nbsp;</strong>Vancomycin is typically used for systemic MRSA infections and is administered intravenously due to poor oral absorption. It is not appropriate for eradicating nasal colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Inhaled colistin:&nbsp;</strong>Colistin is used for multi-drug-resistant gram-negative infections and is not indicated for MRSA, especially not for nasal colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. IV cefazolin:&nbsp;</strong>Cefazolin is a first-generation cephalosporin effective against methicillin-sensitive Staphylococcus aureus (MSSA) but not MRSA. It is also not suitable for treating nasal colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For MRSA colonization in the anterior nares, topical mupirocin is the best treatment due to its targeted action, efficacy, and minimal systemic side effects.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/809</strong></span></p>",
    "correct_choice_id": 28096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16166,
    "choices": [
      {
        "id": 64624,
        "text": "<p><span style=\"font-size:12.0pt;\">Heart failure</span></p>"
      },
      {
        "id": 64625,
        "text": "<p><span style=\"font-size:12.0pt;\">Liver failure</span></p>"
      },
      {
        "id": 64626,
        "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
      },
      {
        "id": 64627,
        "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause of exudative pleural effusion? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q7629486",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855829,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Rheumatoid arthritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Why Rheumatoid Arthritis is Correct:</strong> Rheumatoid arthritis is an inflammatory condition that can lead to the accumulation of exudative pleural effusion. Exudative effusions are characterized by high protein content and cellular debris resulting from increased capillary permeability typically due to inflammation or injury to the pleural membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of an exudative pleural effusion is confirmed using <strong>Light's criteria</strong>, which states that a pleural effusion is exudative if at least one of the following is true:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Pleural fluid protein/serum protein ratio &gt; 0.5</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH/serum LDH ratio &gt; 0.6</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH more than two-thirds the upper limit of normal serum LDH</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heart failure:</strong> Heart failure typically causes a transudative pleural effusion, which results from increased hydrostatic pressure or decreased oncotic pressure without inflammation. The pleural fluid in transudative effusions has low protein content and is generally less cellular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Heart failure is currently the most common cause of pleural effusion (MC cause of transudative pleural effusion).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Liver failure:&nbsp;</strong>Liver failure leads to a <strong>transudative pleural effusion</strong> due to the accumulation of fluid in the abdomen (ascites) that moves into the pleural space, also known as hepatic hydrothorax. This is due to the RAS-activated state causing low protein content in the effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nephrotic syndrome:&nbsp;</strong>Nephrotic syndrome causes a <strong>transudative pleural effusion</strong>. The loss of protein in the urine leads to low serum albumin levels and decreased oncotic pressure, resulting in fluid accumulation in the pleural space.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exudative pleural effusions are typically caused by conditions that involve inflammation or injury to the pleura, such as rheumatoid arthritis, while transudative effusions are usually due to systemic conditions like heart failure, liver failure, and nephrotic syndrome that affect hydrostatic or oncotic pressure.</span></p>",
    "correct_choice_id": 64626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10163,
    "choices": [
      {
        "id": 40618,
        "text": "<p><span style=\"font-size:12.0pt;\">Urine iodine excretion</span></p>"
      },
      {
        "id": 40619,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum thyroid receptor antibody</span></p>"
      },
      {
        "id": 40620,
        "text": "<p><span style=\"font-size:12.0pt;\">Radiotracer uptake with technetium</span></p>"
      },
      {
        "id": 40621,
        "text": "<p><span style=\"font-size:12.0pt;\">Perchlorate secretion test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An 8-day-old newborn was found to have thyroid -stimulating hormone level of more than 100 mlU/L. Which of the following will be the next best investigation? (NEET PG 2022)</span></p>",
    "unique_key": "Q3077899",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855814,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Radiotracer uptake with technetium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The classical presentation is described as the 6 P's of congenital hypothyroidism: pot-belly, pale, puffy-faced child with protruding umbilicus, protuberant tongue, and poor brain development and persistent opening of posterior fontanelle, prolong jaundice &amp; hypotonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given laboratory finding of increased thyroid-stimulating hormone level in an 8-day-old baby is suggestive of congenital hypothyroidism. Radiotracer uptake with technetium will be the next investigation in this condition to confirm the presence of the thyroid gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/4_5dgi5iT.jpg\" alt=\"\" width=\"183\" height=\"275\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture139.jpg\" alt=\"\" width=\"1000\" height=\"586\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Urine iodine excretion:&nbsp;</strong>This test measures the iodine content in urine and is typically used to assess iodine deficiency in populations rather than diagnosing congenital hypothyroidism in an individual.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Serum thyroid receptor antibody:&nbsp;</strong>This test is more relevant in diagnosing autoimmune thyroid diseases such as Graves' disease rather than congenital hypothyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Perchlorate secretion test:&nbsp;</strong>This test is used to identify a defect in thyroid hormone synthesis, particularly in conditions like thyroid dyshormonogenesis, but it is not the first-line investigation for a neonate with high TSH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Radiotracer uptake with technetium is the next best investigation to confirm the presence and function of the thyroid gland in a newborn with elevated TSH.</span></p>",
    "correct_choice_id": 40620,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11610,
    "choices": [
      {
        "id": 46406,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 3</span></p>"
      },
      {
        "id": 46407,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4, 3, 2</span></p>"
      },
      {
        "id": 46408,
        "text": "<p><span style=\"font-size:12.0pt;\">4, 3, 2, 1</span></p>"
      },
      {
        "id": 46409,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 3, 1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with fever and nuchal rigidity. The resident was instructed to perform a lumbar puncture on this patient. What is the correct order of managing this patient?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis</span></li><li><span style=\"font-size:12.0pt;\">Perform guarded lumbar puncture</span></li></ol>",
    "unique_key": "Q7016773",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855824,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 4, 3, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When managing a patient with fever and nuchal rigidity (suggesting possible meningitis), the correct order of steps is:</span></p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h: Establishing IV access is the first priority to ensure hydration and create a route for medication administration.</span></li><li><span style=\"font-size:12.0pt;\">4. Perform guarded lumbar puncture: The lumbar puncture should be performed early to collect CSF samples before antimicrobial therapy alters the CSF findings.</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis: Once the CSF is collected, it must be promptly sent for laboratory analysis to identify potential pathogens and guide targeted therapy.</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone: After CSF collection, empiric antibiotic therapy with ceftriaxone should be initiated. This ensures that treatment doesn't interfere with CSF culture results while still providing timely antimicrobial coverage.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This sequence prioritizes obtaining diagnostic samples before starting antimicrobial therapy, which is critical for accurate diagnosis while not unduly delaying treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In suspected meningitis, the ideal sequence is to secure samples for microbiological diagnosis before starting antibiotics, when clinically feasible. However, if there will be a significant delay in performing the lumbar puncture or if the patient is critically ill, antibiotics should not be delayed. The sequence emphasizes balancing the need for accurate diagnosis with timely intervention.</span></p>",
    "correct_choice_id": 46407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4290,
    "choices": [
      {
        "id": 17137,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow fever</span></p>"
      },
      {
        "id": 17138,
        "text": "<p><span style=\"font-size:12.0pt;\">Crimean-Congo hemorrhagic fever</span></p>"
      },
      {
        "id": 17139,
        "text": "<p><span style=\"font-size:12.0pt;\">Ebola</span></p>"
      },
      {
        "id": 17140,
        "text": "<p><span style=\"font-size:12.0pt;\">Hendra virus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following has been reported to have endemic transmission in India? (INICET MAY 2022)</span></p>",
    "unique_key": "Q4458304",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855844,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Crimean-Congo hemorrhagic fever</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Crimean-Congo haemorrhagic fever (CCHF) is a widespread disease caused by a tick-borne virus</strong> (<strong>Nairovirus) of the Bunyaviridae family</strong>. The CCHF virus causes severe viral haemorrhagic fever outbreaks, with a <strong>case fatality rate of 10\u201340%.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CCHF is endemic in Africa, the Balkans, the Middle East and Asian countries south of the 50th parallel north \u2013 the geographical limit of the principal tick vector. <strong>Outbreak in Gujarat, India</strong> occurred in 2011.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Yellow fever</strong> is mostly endemic to the south and central America, and certain parts of Africa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ebola virus</strong> is located mainly in sub-Saharan Africa</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hendra virus</strong> mainly confined to north-eastern coast of Australia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Crimean-Congo hemorrhagic fever (CCHF) has been reported to have endemic transmission in India, specifically with an outbreak in Gujarat in 2011.</span></p>",
    "correct_choice_id": 17138,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7568,
    "choices": [
      {
        "id": 30240,
        "text": "<p><span style=\"font-size:12pt;\">Chromoblastomycosis</span></p>"
      },
      {
        "id": 30241,
        "text": "<p><span style=\"font-size:12pt;\">Blastomycosis</span></p>"
      },
      {
        "id": 30242,
        "text": "<p><span style=\"font-size:12pt;\">Sporotrichosis</span></p>"
      },
      {
        "id": 30243,
        "text": "<p><span style=\"font-size:12pt;\">Phaeohyphomycosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The farmer presents with a cauliflower-like mass on the foot, which developed after a minor injury, as depicted in the image. Microscopic examination reveals the presence of copper penny bodies. Based on this information, what is the most probable diagnosis? (</span>NEET PG 2022)</p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1342.jpg\" alt=\"\" width=\"300\" height=\"277\"></p>",
    "unique_key": "Q2828541",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855849,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Chromoblastomycosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most likely diagnosis based on the clinical vignette is chromoblastomycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Chromoblastomycosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Causative Organism:</strong>&nbsp; <strong>Fonsecaea, Cladophialophora</strong> species.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical features:</strong> The initial presentation consists of <strong>warty papules </strong>that gradually enlarge, forming a <strong>hypertrophic plaque </strong>resembling <strong>cauliflower</strong>. Over the course of months to years, these lesions progress to large, hyperkeratotic masses with a surface often speckled with black dots.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-131727.png\" alt=\"\" width=\"500\" height=\"499\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Histopathology:</strong> Foreign body granuloma &amp; <strong>Sclerotic / Medlar / Copper penny /Muriform bodies.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Treatment:</strong> Itraconazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Blastomycosis:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Caused by the fungus <strong>Blastomyces dermatitidis.</strong></span></li><li><span style=\"font-size:12pt;\">It primarily affects the <strong>lungs</strong> but can spread to other parts of the body, including the skin.</span></li><li><span style=\"font-size:12pt;\">Skin manifestations can be <strong>ulcerative or verrucous</strong> but the presence of \"copper penny bodies\" is not a characteristic feature of this infection.</span></li><li><span style=\"font-size:12pt;\">Thus, the microscopic finding does not match this option.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sporotrichosis/Rose Gardeners disease.</strong></span></p><p><span style=\"font-size:12pt;\">Few important points about Sporotrichosis:</span></p><ul><li><span style=\"font-size:12pt;\">Caused by <strong>Sporothrix schenckii</strong></span></li><li><span style=\"font-size:12pt;\">An acute or chronic fungal infection where, a linear distribution of nodules is seen Commonly in <strong>gardeners, florists </strong>due to high <strong>thorn prick </strong>possibility.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clinically presents with <strong>Linear noduloulcerative </strong>lesions <strong>(Sporotrichoid) </strong>aligned along lymphatics, with <strong>Satellite</strong> lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sporotrichoid lesions also seen in</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>FISH TANK/SWIMMING POOL GRANULOMA</strong></span></li><li><span style=\"font-size:12pt;\"><strong>LUPUS VULGARIS.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given images show the distribution of lesions along lymphatics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1343.jpg\" alt=\"\" width=\"400\" height=\"225\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Histopathology:</strong></span>&nbsp;<span style=\"font-size:12pt;\"> <strong>Asteroid bodies</strong> are seen.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Treatment:</strong> <strong>Itraconazole / Terbinafine</strong> / Saturated solution of Potassium Iodide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Phaeohyphomycosis:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Represents a group of infections caused by various <strong>dematiaceous fungi.</strong></span></li><li><span style=\"font-size:12pt;\">Lesions can vary in appearance from <strong>nodules to cysts or abscesses</strong>.</span></li><li><span style=\"font-size:12pt;\">Unlike chromoblastomycosis, phaeohyphomycosis does not characteristically have sclerotic or \"copper penny\" bodies under the microscope.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Chromoblastomycosis</strong> is identified by its <strong>clinical</strong> presentation of <strong>verrucous skin</strong> lesions and the <strong>histopathological finding</strong> of <strong>sclerotic or copper penny</strong> bodies, indicative of infection with <strong>dematiaceous fungi.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-132120.png\" alt=\"\" width=\"1000\" height=\"786\"></strong></span></p>",
    "correct_choice_id": 30240,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20454,
    "choices": [
      {
        "id": 81777,
        "text": "<p><span style=\"font-size:12pt;\">Halothane</span></p>"
      },
      {
        "id": 81778,
        "text": "<p><span style=\"font-size:12pt;\">Isoflurane</span></p>"
      },
      {
        "id": 81779,
        "text": "<p><span style=\"font-size:12pt;\">Sevoflurane</span></p>"
      },
      {
        "id": 81780,
        "text": "<p><span style=\"font-size:12pt;\">Desflurane</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is inhalational anesthetic of choice for pediatric age group? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q7315563",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855815,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Sevoflurane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Sevoflurane</strong> is the inhalational anesthetic of choice for pediatric patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points about Sevoflurane:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Sweet Smelling</strong>: Sevoflurane has a pleasant, non-irritating odor, making it easier for children to tolerate during induction.</span></li><li><span style=\"font-size:12pt;\"><strong>Rapid Onset and Offset</strong>: Sevoflurane has a low blood-gas partition coefficient, leading to rapid induction and recovery, which is ideal for pediatric anesthesia.</span></li><li><span style=\"font-size:12pt;\"><strong>Safety Profile</strong>: It has a relatively favorable safety profile for use in children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Halothane</strong>: Halothane was once widely used in pediatric anesthesia but is now less favored due to its potential for causing arrhythmias and hepatotoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Isoflurane</strong>: Isoflurane is effective but has a pungent odor and can be irritating to the respiratory tract, making it less suitable for pediatric induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Desflurane</strong>: Desflurane has a very rapid onset and offset but is highly pungent and can cause airway irritation, making it less suitable for children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sevoflurane is the preferred inhalational anesthetic for pediatric patients due to its rapid onset, pleasant odor, and favorable safety profile. It is particularly useful for inhalational induction, making it easier for children to tolerate the induction process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/25/1.jpg\" alt=\"\" width=\"1000\" height=\"527\"></span></p>",
    "correct_choice_id": 81779,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54264,
    "choices": [
      {
        "id": 216525,
        "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos Syndrome</span></p>"
      },
      {
        "id": 216526,
        "text": "<p><span style=\"font-size:12.0pt;\">Marfan's Syndrome</span></p>"
      },
      {
        "id": 216527,
        "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerosis</span></p>"
      },
      {
        "id": 216528,
        "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following connective tissue degradation disorder is associated with aortic aneurysm?</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1616423",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855839,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Marfan's Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder that affects the body's connective tissues, which provide structural support to various organs and tissues. It is particularly associated with cardiovascular complications, including aortic aneurysms and dissections. This is due to the weakening of the aortic wall caused by defective fibrillin-1, a glycoprotein essential for the elasticity and strength of the connective tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Ehlers-Danlos Syndrome</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">While Ehlers-Danlos Syndrome (EDS) can lead to vascular complications, including aortic aneurysms, it is specifically the vascular type (Type IV) of EDS that is associated with these issues. However, Marfan's Syndrome is more commonly linked to aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Atherosclerosis</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Atherosclerosis is a condition characterized by the build-up of plaque within the arterial walls, leading to narrowing and hardening of the arteries. It is a risk factor for abdominal aortic aneurysm but is not classified as a connective tissue disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Scurvy</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Scurvy is caused by a deficiency in vitamin C, leading to defective collagen synthesis. While it results in symptoms like mucosal bleeding and poor wound healing, it is not associated with aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder closely associated with the development of aortic aneurysms due to the defective fibrillin-1 protein affecting the structural integrity of the aortic wall.</span></p>",
    "correct_choice_id": 216526,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10876,
    "choices": [
      {
        "id": 43470,
        "text": "<p><span style=\"font-size:12.0pt;\">Td dose 0,3</span></p>"
      },
      {
        "id": 43471,
        "text": "<p><span style=\"font-size:12.0pt;\">Tt booster dose</span></p>"
      },
      {
        "id": 43472,
        "text": "<p><span style=\"font-size:12.0pt;\">Td booster dose</span></p>"
      },
      {
        "id": 43473,
        "text": "<p><span style=\"font-size:12.0pt;\">Tt dose 0</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 27-year-old pregnant woman in her second trimester has a 2-year-old child. She received a complete vaccination course during her last pregnancy. What tetanus immunization is recommended for her now? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q6060713",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855838,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Td booster dose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per National Immunization Schedule, the recommendations for pregnant woman are as follows: -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Td-1: Early in pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Td-2: 4 weeks after Td-1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Td-Booster dose: if pregnancy occurs within 3 years of last pregnancy and 2 Td doses were received.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For pregnant women who received the complete Td vaccination course during their last pregnancy within the last three years, a Td booster dose is recommended.</span></p>",
    "correct_choice_id": 43472,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11223,
    "choices": [
      {
        "id": 44858,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low TSH levels</span></span></span></span></p>"
      },
      {
        "id": 44859,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low free T4 levels</span></span></span></span></p>"
      },
      {
        "id": 44860,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low serum T3 levels</span></span></span></span></p>"
      },
      {
        "id": 44861,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive iodine Uptake (RAIU) at 24 hours below normal</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged woman who presented with tremors, palpitations, weight loss, and menstrual irregularities is diagnosed with Graves&#39; disease. Which of the following statements would be correct with respect to her thyroid function test?</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
    "unique_key": "Q6896155",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855851,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Low TSH levels</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Grave&rsquo;s disease in an autoimmune disease characterized by production of antibodies against the TSH-Receptor which stimulates the gland resulting in release of thyroid hormones (T3, T4) producing symptoms of thyrotoxicosis. <strong>Elevated T3, 4 produce reduction in TSH via negative feedback.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B, C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated levels of T3, T4 are seen in Grave&rsquo;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to stimulation of the gland, there is <strong><em>Homogenous uptake </em>on RAIU scan</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm18.jpg\" style=\"height:444px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Graves&#39; disease, low TSH levels are a key diagnostic marker reflecting the increased production and release of thyroid hormones T3 and T4, which exert negative feedback on the pituitary gland to reduce TSH secretion.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Hyperthyroidism/Grave&rsquo;s disease/Chap 384</span></span></strong></p>",
    "correct_choice_id": 44858,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5230,
    "choices": [
      {
        "id": 20892,
        "text": "<p><span style=\"font-size:12.0pt;\">Shift to OT, remove the clots, and cauterize/ligate the vessel</span></p>"
      },
      {
        "id": 20893,
        "text": "<p><span style=\"font-size:12.0pt;\">Shift to OT, start IV antibiotics, and pack the tonsillar fossa</span></p>"
      },
      {
        "id": 20894,
        "text": "<p><span style=\"font-size:12.0pt;\">Give anticoagulants, repeated gargling, and wait for 24 hours</span></p>"
      },
      {
        "id": 20895,
        "text": "<p><span style=\"font-size:12.0pt;\">Do blood transfusion and wait and watch</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient post-tonsillectomy in the recovery room starts bleeding from the operative site. On examination, blood clots are seen. What will be your immediate management? (NEET PG 2021)</span></p>",
    "unique_key": "Q3445958",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855846,
    "difficulty_level": "beginner",
    "subjects_id": [
      9
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Shift to OT, remove the clots, and cauterize/ligate the vessel</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical picture is suggestive of reactionary hemorrhage post-tonsillectomy and the immediate management is to shift the patient to OT, remove the clots, and cauterize/ligate the bleeding vessel.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemorrhage is a common complication of tonsillectomy. It can be primary, reactionary, or secondary:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Primary hemorrhage</strong> occurs at the time of operation. It can be controlled by pressure, ligation, or electrocoagulation of the bleeding vessels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reactionary hemorrhage</strong> occurs within 24 hours. It may be due to dislodgement of the clot, slippage of ligature, or blood pressure returning to normal. It is managed by removal of clot and application of pressure or vasoconstrictor. Ligation or electrocoagulation of the bleeding vessels is done under anesthesia if the above measures fail.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Secondary hemorrhage</strong> is usually seen between the 5th to 10th postoperative day. It is due to sepsis and premature separation of the membrane. Removal of the clot, topical application of dilute adrenaline or hydrogen peroxide with pressure usually suffice. IV antibiotics are given and the bleeding vessel is electro coagulated or ligated if bleeding continues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The immediate return to the OT for direct intervention is essential in managing post-tonsillectomy bleeding. Ensuring the bleeding vessel is adequately addressed through cauterization or ligation can prevent further complications and promote healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 504, 505</strong></span></p>",
    "correct_choice_id": 20892,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10212,
    "choices": [
      {
        "id": 40814,
        "text": "<p><span style=\"font-size:18px;\">Cardiovascular diseases</span></p>"
      },
      {
        "id": 40815,
        "text": "<p><span style=\"font-size:18px;\">Cervical Cancer</span></p>"
      },
      {
        "id": 40816,
        "text": "<p><span style=\"font-size:18px;\">Breast Cancer</span></p>"
      },
      {
        "id": 40817,
        "text": "<p><span style=\"font-size:18px;\">Road Traffic Accidents</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>The scope of Project MONICA includes: </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q6338313",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855825,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Cardiovascular diseases&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Project MONICA is related to cardiovascular diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The WHO MONICA (<strong>MONI</strong>toring trends and determinants in <strong>CA</strong>rdiovascular disease) Project was designed to measure trends and determinants in cardiovascular disease mortality and coronary heart disease and cerebrovascular disease morbidity, and to assess the extent to which these trends are related to changes in known risk factors in different populations in 27 countries (10 years\u2019 period)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The scope of Project MONICA is focused on cardiovascular diseases, specifically monitoring trends in coronary heart disease and cerebrovascular disease and examining the impact of various risk factors on these conditions.</span></p>",
    "correct_choice_id": 40814,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13127,
    "choices": [
      {
        "id": 52470,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
      },
      {
        "id": 52471,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3 only</span></p>"
      },
      {
        "id": 52472,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4 and 5 only</span></p>"
      },
      {
        "id": 52473,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following helps to differentiate a fixed dilated pupil? (</span>INICET Nov 2020)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Phenylephrine</span></li><li><span style=\"font-size:12.0pt;\">1% Pilocarpine</span></li><li><span style=\"font-size:12.0pt;\">0.1% Pilocarpine</span></li><li><span style=\"font-size:12.0pt;\">Cocaine 0.5%</span></li><li><span style=\"font-size:12.0pt;\">Epinephrine</span></li></ol>",
    "unique_key": "Q4216485",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855827,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pilocarpine is used to differentiate fixed dilated pupils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. 1% Pilocarpine</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-120120.png\" alt=\"\" width=\"1000\" height=\"364\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. 0.1% Pilocarpine</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture97.jpg\" alt=\"\" width=\"1000\" height=\"150\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Phenylephrine:</strong> This is a sympathomimetic agent that typically dilates the pupil and is not used for differentiating causes of fixed dilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Cocaine 0.5%:</strong> Cocaine tests for anisocoria primarily in the context of Horner\u2019s syndrome. It blocks the reuptake of norepinephrine, failing to dilate a Horner\u2019s pupil due to sympathetic chain lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture98.jpg\" alt=\"\" width=\"1000\" height=\"144\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - </strong>Cocaine and 1% hydroxy amphetamine are used to evaluate anisocoria in smaller pupil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture99.jpg\" alt=\"\" width=\"1000\" height=\"298\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Epinephrine:</strong> Similar to phenylephrine, epinephrine is not used to differentiate fixed dilated pupils but rather to induce dilation for diagnostic or therapeutic purposes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pilocarpine at concentrations of 1% and 0.1% is crucial for differentiating causes of fixed dilated pupils, with 1% identifying pharmacological blockade or nerve palsy, and 0.1% detecting hypersensitivity in cases like Adie's pupil.</span></p>",
    "correct_choice_id": 52471,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 34042,
    "choices": [
      {
        "id": 136003,
        "text": "<p><span style=\"font-size:12.0pt;\">Green</span></p>"
      },
      {
        "id": 136004,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span></p>"
      },
      {
        "id": 136005,
        "text": "<p><span style=\"font-size:12.0pt;\">Pink</span></p>"
      },
      {
        "id": 136006,
        "text": "<p><span style=\"font-size:12.0pt;\">Black</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old child who is eagerly drinking water and skin pinch goes back slowly. Which category does the child belong according to IMNCI? (FMGE JAN 2024)</span></p>",
    "unique_key": "Q6264469",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855835,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Yellow</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Integrated Management of Neonatal and Childhood Illness (IMNCI) is a strategy developed by the World Health Organization (WHO) and UNICEF to improve child health in developing countries. The child's symptoms of eagerly drinking water and a slow skin pinch return are indicative of some dehydration, which falls under the yellow category in the IMNCI guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Green</strong>: The green category denotes \"no dehydration.\" This would be for a child who shows no signs of dehydration and is otherwise healthy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pink</strong>: The pink category denotes \"severe dehydration.\" Signs of severe dehydration include lethargy, unconsciousness, very dry mouth, and a skin pinch that goes back very slowly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Black</strong>: This is an incorrect option as the IMNCI color coding does not include black.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the IMNCI color coding system:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Green indicates no dehydration.</span></li><li><span style=\"font-size:12.0pt;\">Yellow indicates some dehydration.</span></li><li><span style=\"font-size:12.0pt;\">Pink indicates severe dehydration.</span></li></ul>",
    "correct_choice_id": 136004,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15610,
    "choices": [
      {
        "id": 62400,
        "text": "<p><span style=\"font-size:12.0pt;\">4 years</span></p>"
      },
      {
        "id": 62401,
        "text": "<p><span style=\"font-size:12.0pt;\">7 years</span></p>"
      },
      {
        "id": 62402,
        "text": "<p><span style=\"font-size:12.0pt;\">10 years</span></p>"
      },
      {
        "id": 62403,
        "text": "<p><span style=\"font-size:12.0pt;\">13 years</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the most probable age of the child under POCSO (Protection of Children from Sexual Offences) Act by looking at the X-ray below:(NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1309.jpg\" alt=\"\" width=\"300\" height=\"286\"></span></p>",
    "unique_key": "Q5019309",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855843,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 7 years</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The X-ray shows 7 Carpal bones. Thus, minimum age is 5 here.</span></li><li><span style=\"font-size:12.0pt;\">Also, pisiform is not seen. Hence, the age is between 5-12.</span></li><li><span style=\"font-size:12.0pt;\">The best answer is 7 years as the normal age range for appearance of pisiform is 8-12 years.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>BONE AGE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Left hand and wrist X-ray PA view \u2013 most commonly used for bone age assessment \u2013 Based on appearance of carpal bones</span></li><li><span style=\"font-size:12.0pt;\">First to appear is Capitate, then in a counter-clockwise fashion except pisiform which is the last carpal bone to appear</span></li><li><span style=\"font-size:12.0pt;\">Pisiform is ossified at the age of nine to 13 years as evident from different studies.</span></li><li><span style=\"font-size:12.0pt;\">The appearance of ossification center of pisiform bone is one of the important evidence for estimating age among young children between nine to 13 years.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/screenshot-2024-01-03-120733.jpg\" alt=\"\" width=\"600\" height=\"697\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The x-ray shown in the image suggests the age of the child to be 7 years as the x-ray does not have the Pisiform bone.</span></li><li><span style=\"font-size:12.0pt;\">Pisiform bone ossifies by the age of 13.</span></li></ul>",
    "correct_choice_id": 62401,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14345,
    "choices": [
      {
        "id": 57341,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin falls from 11g% to 10g%</span></p>"
      },
      {
        "id": 57342,
        "text": "<p><span style=\"font-size:12.0pt;\">Extraperitoneal bladder rupture</span></p>"
      },
      {
        "id": 57343,
        "text": "<p><span style=\"font-size:12.0pt;\">Pneumoperitoneum</span></p>"
      },
      {
        "id": 57344,
        "text": "<p><span style=\"font-size:12.0pt;\">Distended gallbladder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What sign on day 2 would indicate a need for surgery in a patient who was conservatively managed in the ICU after grade 3 splenic trauma? &nbsp;</span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q8513845",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855840,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pneumoperitoneum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of pneumoperitoneum on imaging would indicate a need for laparotomy as it suggests visceral perforation, which can lead to secondary peritonitis. Conservative management is usually recommended for splenic trauma, and surgical management is reserved for cases of hemodynamic instability or failure to respond to conservative management. Splenic angiography and embolization are also used for non-surgical management. The severity of splenic injury is graded by the AST spleen injury scale, and abdominal CT with intravenous contrast is the preferred investigation. A drop of 1g% of hemoglobin may be a physiological finding, and would not warrant a surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Extraperitoneal bladder rupture can be managed with a urinary catheter, while distended gall bladder is a normal finding if patient has been nil per oral.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Grades of splenic trauma based on the American Association for the Surgery of Trauma (AAST) spleen injury scale:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-123251.png\" alt=\"\" width=\"1000\" height=\"296\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pneumoperitoneum, the presence of air in the abdominal cavity, is a concerning sign and typically indicates a perforation of the gastrointestinal tract or another abdominal organ. In a patient with grade 3 splenic trauma, the development of pneumoperitoneum suggests a concomitant hollow viscous perforation and would likely necessitate surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemoglobin falls from 11g% to 10g%</strong>: A drop in hemoglobin levels can be indicative of ongoing bleeding but may not be an immediate indication for surgery. It would typically be monitored closely, and the need for surgery would depend on the rate of decline and the overall clinical condition of the patient. Typically, a decline by &gt;2g% Hb is suggestive of active bleed and warrants further management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Extraperitoneal bladder rupture</strong>: While extraperitoneal bladder rupture is a serious condition, it is not directly related to splenic trauma. Its management involves keeping a per urethral Foleys and allowing the rupture to heal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Distended Gall bladder</strong>: This is a normal physiological finding and does not mandate surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pneumoperitoneum is the most concerning sign in a patient with grade 3 splenic trauma and would indicate a need for surgery, as it suggests a perforation.</span></p>",
    "correct_choice_id": 57343,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52123,
    "choices": [
      {
        "id": 207993,
        "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcal</span></p>"
      },
      {
        "id": 207994,
        "text": "<p><span style=\"font-size:12.0pt;\">Meningococcal</span></p>"
      },
      {
        "id": 207995,
        "text": "<p><span style=\"font-size:12.0pt;\">H. influenzae</span></p>"
      },
      {
        "id": 207996,
        "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following does not have polysaccharide vaccine?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q4398637",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855842,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polysaccharide vaccines are typically made from the polysaccharide capsule that surrounds certain bacteria. These vaccines are designed to protect against bacterial infections by inducing immunity against the polysaccharide antigens present in the capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hepatitis B vaccine is not a polysaccharide vaccine. It is a recombinant vaccine that uses a portion of the hepatitis B virus (HBsAg - hepatitis B surface antigen) produced in yeast cells. This vaccine does not involve a polysaccharide component as the hepatitis B virus does not have a polysaccharide capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumococcal:&nbsp;</strong>The pneumococcal vaccine is available in both polysaccharide (PPSV23) and conjugate forms (PCV13), targeting the polysaccharide capsule of Streptococcus pneumoniae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Meningococcal:&nbsp;</strong>Meningococcal vaccines also include polysaccharide (MPSV4) and conjugate forms (MCV4), aimed at the polysaccharide capsule of Neisseria meningitidis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. H. influenzae:&nbsp;</strong>The Haemophilus influenzae type b (Hib) vaccine is a conjugate vaccine that includes the polysaccharide antigen from the bacterial capsule conjugated to a protein carrier.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hepatitis B vaccine is a recombinant vaccine, not a polysaccharide vaccine, as it targets a virus that does not have a polysaccharide capsule.</span></p>",
    "correct_choice_id": 207996,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55415,
    "choices": [
      {
        "id": 221121,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It inhibits dihydrofolate reductase</span></span></p>"
      },
      {
        "id": 221122,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It acts as an alkylating agent</span></span></p>"
      },
      {
        "id": 221123,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It inhibits topoisomerase II</span></span></p>"
      },
      {
        "id": 221124,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It inhibits polymerization of tubulin monomers in mitosis</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What is the mechanism of action of methotrexate in the treatment of cancer? (FMGE JULY 2024)</span></span></p>",
    "unique_key": "Q9515878",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855852,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) It inhibits dihydrofolate reductase</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate is an antimetabolite and antifolate drug used in the treatment of various types of cancer. Its primary mechanism of action is the inhibition of the enzyme dihydrofolate reductase (DHFR). DHFR is crucial for the synthesis of tetrahydrofolate, which is necessary for the synthesis of purines and thymidylate, essential components of DNA. By inhibiting DHFR, methotrexate leads to the depletion of tetrahydrofolate and ultimately inhibits DNA synthesis, cell replication, and cell function, which is particularly effective against rapidly dividing cancer cells.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Acts as an alkylating agent:</strong> Alkylating agents work by adding an alkyl group to the DNA molecule, which can lead to DNA strand breaks and cell death. Methotrexate does not work by this mechanism.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Inhibits topoisomerase II:</strong> Topoisomerase II inhibitors prevent the DNA from uncoiling and duplicating. Drugs like etoposide and doxorubicin work by this mechanism.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Inhibits polymerization of tubulin monomers in mitosis:</strong> This is the mechanism of action of drugs like vincristine and paclitaxel, which interfere with microtubule formation and function.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate exerts its anticancer effects primarily by inhibiting the enzyme dihydrofolate reductase, thereby blocking the synthesis of DNA and RNA necessary for cell replication.</span></span></p>",
    "correct_choice_id": 221121,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 23221,
    "choices": [
      {
        "id": 92848,
        "text": "<p><span style=\"font-size:12pt;\">Anovulation</span></p>"
      },
      {
        "id": 92849,
        "text": "<p><span style=\"font-size:12pt;\">Endometriosis</span></p>"
      },
      {
        "id": 92850,
        "text": "<p><span style=\"font-size:12pt;\">Malignancy</span></p>"
      },
      {
        "id": 92851,
        "text": "<p><span style=\"font-size:12pt;\">Bleeding disorder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of puberty menorrhagia?&nbsp;</span>(INICET MAY 2023)</p>",
    "unique_key": "Q3244151",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855823,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Anovulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anovulation is the most common cause of puberty menorrhagia. Menorrhagia refers to heavy menstrual bleeding that occurs in a regular cycle. In adolescents, anovulation, which is the failure of the ovary to release an oocyte during a menstrual cycle, frequently leads to heavy or prolonged bleeding due to the lack of a normal hormonal cycle that regulates the endometrial lining. Without the usual cyclical hormonal fluctuations, the endometrial lining may become excessively thick, leading to heavy bleeding when it sheds. This condition is typical in puberty due to the body's ongoing adjustment to hormonal regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Endometriosis</strong>: Endometriosis involves the presence of endometrial tissue outside the uterus, which can cause painful menstruation and potentially contribute to menorrhagia. However, it is less common than anovulation as the primary cause of menorrhagia in adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Malignancy</strong>: Malignancy is a rare cause of menorrhagia in puberty. While malignancy can lead to abnormal bleeding, it is not the most common cause in this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bleeding disorder</strong>: Bleeding disorders such as von Willebrand disease or hemophilia can cause menorrhagia but are less common compared to anovulation in adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anovulation is the most common cause of menorrhagia in puberty.</span></p>",
    "correct_choice_id": 92848,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54261,
    "choices": [
      {
        "id": 216513,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true and reason is the correct explanation of assertion</span></span></p>"
      },
      {
        "id": 216514,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true but reason is not the correct explanation of assertion</span></span></p>"
      },
      {
        "id": 216515,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is true, reason is false</span></span></p>"
      },
      {
        "id": 216516,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is false, reason is true</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Assertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Myocarditis is seen as a complication of diphtheria.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Reason</strong>: It is due to bacteremia.&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1669572",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855841,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Assertion is true, reason is false</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The assertion that myocarditis is seen as a complication of diphtheria is correct. Myocarditis is a well-known and serious complication of diphtheria, often leading to significant morbidity and mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The reason provided, that myocarditis is due to bacteremia, is incorrect. The complications of diphtheria, including myocarditis, are primarily due to the effects of the diphtheria toxin (toxemia), not bacteremia. The toxin affects various organs, including the heart, leading to myocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myocarditis is a complication of diphtheria caused by the diphtheria toxin (toxemia), not by bacteremia.</span></span></span></p>",
    "correct_choice_id": 216515,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57437,
    "choices": [
      {
        "id": 229121,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzathine penicillin G 2.4 Million Units intramuscularly</span></span></p>"
      },
      {
        "id": 229122,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefixime 400 mg orally</span></span></p>"
      },
      {
        "id": 229123,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole 500 mg thrice a day</span></span></p>"
      },
      {
        "id": 229124,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxycycline 100 mg twice a day</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male presents to the clinic with complaints of burning sensation during urination and a purulent discharge from the penis for the past 5 days. He has had unprotected sexual intercourse with a new partner two weeks ago. On examination, the urethral meatus is erythematous, and there is a noticeable purulent discharge. A Gram stain of the discharge reveals intracellular gram-negative diplococci. The patient is otherwise healthy and has no known drug allergies. What is the most appropriate treatment for this patient? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q8179226",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855834,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cefixime 400 mg orally</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms, along with the Gram stain revealing intracellular gram-negative diplococci, strongly indicate a diagnosis of <strong>gonorrhea</strong>, a sexually transmitted infection caused by <em>Neisseria gonorrhoeae</em>. The recommended treatment for uncomplicated gonococcal infections, especially in cases of urethritis, involves the use of cephalosporins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug of choice for gonorrhea is <strong>Ceftriaxone</strong>, typically administered as an intramuscular injection. However, in this case, an oral cephalosporin, <strong>Cefixime 400 mg</strong>, is a suitable alternative, especially if the patient prefers oral medication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Benzathine penicillin G</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the treatment of choice for syphilis, not gonorrhea. The patient&rsquo;s presentation does not suggest syphilis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metronidazole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is used primarily for bacterial vaginosis and trichomoniasis. It is not effective against gonorrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Doxycycline</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While doxycycline is used to treat certain sexually transmitted infections, such as Chlamydia trachomatis and lymphogranuloma venereum, it is not the first-line treatment for gonorrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefixime 400 mg orally</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an effective oral treatment option for gonorrhea, particularly in patients who prefer to avoid injections. The presence of intracellular gram-negative diplococci in a symptomatic patient strongly suggests gonococcal infection, requiring prompt and appropriate antibiotic therapy.</span></span></span></p>",
    "correct_choice_id": 229122,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11222,
    "choices": [
      {
        "id": 44854,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 130/80 mmHg</span></span></span></span></p>"
      },
      {
        "id": 44855,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 140/90 mmHg</span></span></span></span></p>"
      },
      {
        "id": 44856,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 150/100 mmHg</span></span></span></span></p>"
      },
      {
        "id": 44857,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 160/100 mmHg</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male patient has been diagnosed with hypertension. On examination, there is no existing cardiovascular disease, no hypertension-mediated organ damage (HMOD), and the renal function is normal. He should be immediately started on pharmacological management if his blood pressure is more than:</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
    "unique_key": "Q8753055",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855819,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. &gt; 160/100 mmHg</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ISH (International society of HTN) 2020 guidelines were made to help decision making in low-middle income countries.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of ASCVD risk factors, HMOD (HTN mediated organ damage) is an indication to start anti-HTN therapy.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Home BP recording helps in diagnosis of <strong>Masked HTN</strong>, <strong>rule out white-coat effect</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABPM provides 24-hour trend and fluctuations in BP.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164121.jpg\" style=\"height:417px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Home BP &gt; 135/85 mmHg </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">= HTN</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABPM cutoffs:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mean Awake (daytime) average &ge; 135/85 mmHg</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">24h average &ge; 130/80 mmHg</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mean Asleep(night) &ge; 120/70 mmHg</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP drops at night by (10-20%), morning surge &ndash; Steep increase, peaks in late afternoon.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Best observed in ABPM&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ambulatory BP monitoring)<strong>:</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal Dip: 10-20 % at night</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extreme Dip &gt; 20%</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-dippers &lt; 10%&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(A/w Activation of RAAS)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risers: BP raise</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase mortality risk among Non-Dippers and Risers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate pharmacological treatment for hypertension in patients without additional cardiovascular risk factors or organ damage should commence when blood pressure levels exceed 160/100 mmHg, according to the ISH 2020 guidelines. This approach helps to target treatment to those most likely to benefit from immediate intervention, balancing the benefits and risks of pharmacotherapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: ISH2020, AHA2017 HTN guidelines</span></span></strong></p>",
    "correct_choice_id": 44857,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "OlderNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54950,
    "choices": [
      {
        "id": 219261,
        "text": "<p><span style=\"font-size:12.0pt;\">Anemia of chronic disease</span></p>"
      },
      {
        "id": 219262,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 219263,
        "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
      },
      {
        "id": 219264,
        "text": "<p><span style=\"font-size:12.0pt;\">Pernicious anemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the most common anemia in a 65-year-old female? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q8906863",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855831,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Iron deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is the most common type of anemia globally, including in a 65-year-old female. While it is true that menstruation is a common cause of iron deficiency anemia in younger women, older women can still be susceptible due to other factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In elderly patients, particularly in females, iron deficiency anemia can arise from a variety of causes, including:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Nutritional deficiencies:</strong> This remains a leading cause, especially in developing countries where dietary iron intake may be insufficient.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Gastrointestinal blood loss:</strong> This is a significant concern in elderly patients. Conditions such as peptic ulcers, hemorrhoids, and gastrointestinal malignancies (like colon cancer) are common causes of chronic blood loss, leading to iron deficiency anemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Malabsorption syndromes:</strong> Conditions that impair the absorption of iron from the gastrointestinal tract can also contribute to iron deficiency anemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The confusion might arise from the assumption that post-menopausal women are less likely to suffer from iron deficiency anemia due to the cessation of menstrual bleeding. However, it is important to recognize that other causes, especially chronic blood loss from the gastrointestinal tract, become more prevalent with age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anemia of chronic disease:</strong> This type of anemia is common in the elderly, particularly those with chronic illnesses like rheumatoid arthritis or chronic infections. However, iron deficiency anemia remains the most common overall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Megaloblastic anemia:</strong> This anemia is usually due to deficiencies in vitamin B12 or folate. While it is more common in the elderly, it is not as prevalent as iron deficiency anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pernicious anemia:</strong> A specific type of megaloblastic anemia caused by vitamin B12 deficiency due to intrinsic factor deficiency. While it can be common in older adults, it is not the most common cause of anemia overall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is the most common type of anemia in a 65-year-old female, with causes shifting from menstrual blood loss in younger women to chronic gastrointestinal blood loss (due to malignancies) and nutritional deficiencies in the elderly.</span></p>",
    "correct_choice_id": 219262,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5229,
    "choices": [
      {
        "id": 20888,
        "text": "<p><span style=\"font-size:12.0pt;\">Ligation of external carotid artery</span></p>"
      },
      {
        "id": 20889,
        "text": "<p><span style=\"font-size:12.0pt;\">Ligation of internal carotid artery</span></p>"
      },
      {
        "id": 20890,
        "text": "<p><span style=\"font-size:12.0pt;\">Ligation of sphenopalatine artery</span></p>"
      },
      {
        "id": 20891,
        "text": "<p><span style=\"font-size:12.0pt;\">Ligation of maxillary artery</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents to the emergency with epistaxis. There was no relief on pinching the nostrils. Nasal packing was done but the patient still continues to bleed. What would be the next appropriate step in the management of this patient? (NEET PG 2021)</span></p>",
    "unique_key": "Q2509103",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855830,
    "difficulty_level": "beginner",
    "subjects_id": [
      9
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ligation of sphenopalatine artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sphenopalatine artery ligation should be considered in cases where epistaxis is not controlled by trotters method or nasal packing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ligation should be performed as close as possible to the likely bleeding point.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Most common artery to be ligated for epistaxis is Sphenopalatine artery followed by internal maxillary artery, External carotid artery, Anterior /posterior ethmoidal artery.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/2_V1ZM7fV.jpg\" alt=\"\" width=\"700\" height=\"1191\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ligation of external carotid artery:&nbsp;</strong>The external carotid artery is a major artery that supplies blood to numerous facial structures, including the scalp, face, jaw, and more. Ligation of this artery is generally considered a more drastic measure and is typically reserved for severe cases where other specific arterial sources of bleeding have been ruled out or are inaccessible. It is much less selective than targeting the sphenopalatine artery and can lead to significant complications due to reduced blood flow to essential tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ligation of internal carotid artery:&nbsp;</strong>This option is generally not considered for epistaxis management due to the critical nature of the internal carotid artery, which primarily supplies blood to the brain. Ligation of this artery would pose a high risk of serious neurological deficits or stroke. It is a major artery and not a contributor to nasal bleeding; thus, it is not targeted in the treatment of epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ligation of maxillary artery:&nbsp;</strong>The maxillary artery is a major artery within the face that branches off the external carotid artery and gives rise to the sphenopalatine artery. While ligation of the maxillary artery is an option for severe epistaxis, it is less specific than targeting the sphenopalatine artery. The maxillary artery supplies areas broader than just the nasal cavity, including the maxilla, mandible, teeth, and parts of the face. Therefore, ligation of this artery is considered more invasive and has a higher risk of complications compared to the sphenopalatine artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sphenopalatine artery ligation is a highly effective surgical procedure for controlling severe or refractory epistaxis after more conservative measures have failed. This approach targets a primary blood supply to the nasal cavity, significantly reducing the risk of further bleeding.</span></p>",
    "correct_choice_id": 20890,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20839,
    "choices": [
      {
        "id": 83320,
        "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
      },
      {
        "id": 83321,
        "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
      },
      {
        "id": 83322,
        "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
      },
      {
        "id": 83323,
        "text": "<p><span style=\"font-size:12.0pt;\">Penicillin G</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A man presents with a history of dysuria and urethral discharge after having unprotected sexual intercourse. Gram-staining of the purulent discharge is seen in the following image. What is the treatment of choice for this infection? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture45.jpg\" alt=\"\" width=\"400\" height=\"264\"></span></p>",
    "unique_key": "Q8030594",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ceftriaxone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The symptoms with the microscopic findings which shows gram-negative intracellular diplococci suggests infection with Neisseria gonorrhoeae. The treatment of choice for the infection is ceftriaxone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment of Gonorrhoea \u2013</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Third generation cephalosporins \u2013 DOC for uncomplicated gonococcal infection - both the sexual partners should be treated.</span></li><li><span style=\"font-size:12.0pt;\">Ceftriaxone (250 mg given IM, single dose)</span></li><li><span style=\"font-size:12.0pt;\">Cefixime (400 mg given orally, single dose)</span></li><li><span style=\"font-size:12.0pt;\">If coexisting chlamydial infection \u2013 azithromycin or doxycycline added.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Erythromycin&nbsp;</strong>and <strong>Option B. Azithromycin</strong> are macrolides, generally used for chlamydial infections or as a co-treatment when chlamydia is suspected alongside gonorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Penicillin G</strong> is no longer recommended as the primary treatment for gonorrhea due to widespread resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For uncomplicated gonorrhea, especially cases presenting with urethral discharge and identified intracellular gram-negative diplococci, Ceftriaxone remains the treatment of choice. This choice reflects current guidelines that prioritize efficacy and resistance profiles in managing sexually transmitted infections.</span></p>",
    "correct_choice_id": 83322,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 21889,
    "choices": [
      {
        "id": 87524,
        "text": "<p><span style=\"font-size:12.0pt;\">Teriparatide should be given before supplementing bisphosphonates one at a time.</span></p>"
      },
      {
        "id": 87525,
        "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates are not given for more than one year.</span></p>"
      },
      {
        "id": 87526,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcium requirement is 1200 mg per day.</span></p>"
      },
      {
        "id": 87527,
        "text": "<p><span style=\"font-size:12.0pt;\">Oral Vitamin D3 given along with oral calcium.</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A post-menopausal woman with previous history of Colle\u2019s fracture is complaining of backache. Which of the following statement is false?&nbsp;</span>&nbsp;(NEET PG 2021)</p>",
    "unique_key": "Q7772586",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855826,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Bisphosphonates are not given for more than one year.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOPOROSIS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osteoporosis is <strong>reduction in bone mass (density)</strong> i.e., there is <strong>quantitative decrease of units of bone formation</strong> but each unit has qualitatively normal configuration.</span></li><li><span style=\"font-size:12.0pt;\">So, osteoporosis characteristically has <strong>normal calcium, phosphate and alkaline phosphatase levels</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Bone Mineral Density is measured by DEXA (Dual Emission X-ray Absorptiometry) Scan and it is matched to DEXA scan of 30-year-old individual of the same sex and T score is calculated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-192616.jpg\" alt=\"\" width=\"1000\" height=\"479\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Etiology of Osteoporosis:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-192803.jpg\" alt=\"\" width=\"1000\" height=\"365\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Imaging:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Radiological features are <strong>loss of vertical height of vertebrae</strong> (collapse) and <strong>codfish appearance </strong>(concave superior and inferior surfaces) of vertebrae.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture69.jpg\" alt=\"\" width=\"250\" height=\"313\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>X-ray of osteoporotic spine: Codfish vertebra</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Singh\u2019s Index</strong> is used for osteoporosis grading.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:&nbsp;</strong>Drugs used in osteoporosis are:</span><ol><li><span style=\"font-size:12.0pt;\"><strong>Inhibit resorption:</strong> Bisphosphonates (drug of choice), Denosumab, calcitonin, estrogen, SERMS, gallium nitrate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stimulate formation:</strong> Teriparatide (PTH analogue), calcium, calcitriol, fluorides.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Both actions:</strong> Strontium ranelate</span><br>&nbsp;</li></ol></li><li><span style=\"font-size:12.0pt;\">Bisphosphonases are not metabolized and are excreted intact in urine. Their t 1/2 is 1-10 years and cessation of treatment does not lead to rapid bone loss. These drugs decrease the incidence of vertebral and non vertebral fractures.</span></li><li><span style=\"font-size:12.0pt;\">Prolonged used of Bisphosphonates has been reported with increased incidence of fractures of proximal femur. Hence, a patient on Bisphosphonates with hip pain requires X-rays to evaluate and diagnose these fractures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Teriparatide should be given before supplementing bisphosphonates one at a time.&nbsp;</strong>Teriparatide is a recombinant fragment of human parathyroid hormone. To preserve the increments of BMD acquired with teriparatide, therapy with an antiresorptive agent (e.g., bisphosphonates) should restart after teriparatide discontinuation.&nbsp;Bisphosphonates help retain BMD gains that tend to regress after cessation of teriparatide. Concomitant use with teriparatide is to be avoided because they may blunt its anabolic effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Calcium requirement is 1200 mg per day.&nbsp;</strong>1200 mg of calcium (total of diet and supplement) and 800 international units of vitamin D daily for postmenopausal osteoporosis are recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oral Vitamin D3 given along with oral calcium.&nbsp;</strong>Calcium and vitamin D supplementation is a necessary adjunct to all forms of anti-osteoporotic therapies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In post-menopausal osteoporotic females, bisphosphonates can be given for more than a year.</span></li><li><span style=\"font-size:12.0pt;\">But their prolonged use is associated with risk of hip fractures, so it should be assessed with x-rays with time.</span></li></ul>",
    "correct_choice_id": 87525,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6085,
    "choices": [
      {
        "id": 24309,
        "text": "<p><span style=\"font-size:12.0pt;\">Feeble mindedness</span></p>"
      },
      {
        "id": 24310,
        "text": "<p><span style=\"font-size:12.0pt;\">Mental subnormality</span></p>"
      },
      {
        "id": 24311,
        "text": "<p><span style=\"font-size:12.0pt;\">Intellectual disability</span></p>"
      },
      {
        "id": 24312,
        "text": "<p><span style=\"font-size:12.0pt;\">Intellectually challenged</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is 'mental retardation' now called according to the American Psychiatric Association in its revision of DSM-5?&nbsp;(NEET PG 2018)</span></p>",
    "unique_key": "Q1673552",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855837,
    "difficulty_level": "beginner",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Intellectual disability</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The term \"mental retardation\" has historically been used in clinical and diagnostic settings, but it has now been largely replaced due to its potential for stigmatization and pejorative connotations. In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) by the American Psychiatric Association, the term \"mental retardation\" has been updated to: <strong>Intellectual disability (intellectual developmental disorder)</strong>. This term is more respectful and emphasizes the abilities of the individual, rather than just their limitations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Feeble mindedness and option B. Mental subnormality</strong> are outdated and non-specific terms that were used in the past.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intellectually challenged</strong> is a non-clinical term that may be used colloquially to describe someone with intellectual disabilities in a more respectful manner.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's essential to understand that the term \"mental retardation\" is now outdated and has been replaced with \"intellectual disability\" in clinical settings, especially according to DSM-5, to ensure respectful and non-stigmatizing communication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 1118-1119.</strong></span></p>",
    "correct_choice_id": 24311,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5941,
    "choices": [
      {
        "id": 23734,
        "text": "<p><span style=\"font-size:12pt;\">Prevention of seizures in severe pre-eclampsia</span></p>"
      },
      {
        "id": 23735,
        "text": "<p><span style=\"font-size:12pt;\">Prevention of recurrent seizures in eclampsia</span></p>"
      },
      {
        "id": 23736,
        "text": "<p><span style=\"font-size:12pt;\">Prevention of RDS in premature baby</span></p>"
      },
      {
        "id": 23737,
        "text": "<p><span style=\"font-size:12pt;\">Reducing contractility of uterus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulphate has no role in? (NEET PG 2019)</span></p>",
    "unique_key": "Q2178849",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855833,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Prevention of RDS in premature baby</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Magnesium Sulphate (MgSO4):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">MgSO4 is used for several obstetric indications, including:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Eclampsia:</strong> MgSO4 is the drug of choice for the prevention and treatment of seizures in eclampsia.</span></li><li><span style=\"font-size:12pt;\"><strong>Prevention of Seizures in Severe Pre-eclampsia:</strong> It is used prophylactically to prevent seizures in women with severe pre-eclampsia.</span></li><li><span style=\"font-size:12pt;\"><strong>Tocolytic in Preterm Labor:</strong> MgSO4 is used as a tocolytic agent to reduce uterine contractions and delay preterm labor.</span></li><li><span style=\"font-size:12pt;\"><strong>Neuroprotection in Severe Preterm Infants (&lt;29 weeks):</strong> MgSO4 is administered to provide neuroprotection for the fetus, reducing the risk of cerebral palsy and other neurological disorders in preterm infants.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Prevention of RDS (Respiratory Distress Syndrome) in Premature Baby:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">MgSO4 does not play a role in the prevention of RDS. Instead, corticosteroids (such as betamethasone or dexamethasone) are used to accelerate fetal lung maturation and reduce the risk of RDS in preterm babies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prevention of Seizures in Severe Pre-eclampsia:</strong> MgSO4 is effectively used to prevent seizures in women with severe pre-eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Prevention of Recurrent Seizures in Eclampsia:</strong> MgSO4 is the preferred treatment to prevent recurrent seizures in women with eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Reducing Contractility of Uterus:</strong> MgSO4 is used as a tocolytic agent to reduce uterine contractility and delay preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Corticosteroids are used for the prevention of respiratory distress syndrome in preterm babies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 1860, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 23736,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 51045,
    "choices": [
      {
        "id": 203709,
        "text": "<p><span style=\"font-size:12pt;\">Alveolar sac</span></p>"
      },
      {
        "id": 203710,
        "text": "<p><span style=\"font-size:12pt;\">Respiratory bronchus</span></p>"
      },
      {
        "id": 203711,
        "text": "<p><span style=\"font-size:12pt;\">Terminal bronchiole</span></p>"
      },
      {
        "id": 203712,
        "text": "<p><span style=\"font-size:12pt;\">Intrapulmonary bronchiole</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure indicated by the arrow:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-104233.png\" alt=\"\" width=\"400\" height=\"306\"></p>",
    "unique_key": "Q2203907",
    "question_audio": null,
    "question_video": null,
    "map_id": 20855853,
    "difficulty_level": "difficult",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Respiratory bronchus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-104310.png\" alt=\"\" width=\"600\" height=\"621\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The image shows a histological section of the lung with an arrow indicating a structure involved in gas exchange. The key features to identify include the presence of air spaces and the type of epithelium lining these spaces.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Respiratory Bronchus:</strong> This structure is part of the respiratory zone of the lung, where gas exchange occurs. It is lined by simple cuboidal epithelium transitioning to simple squamous epithelium as it progresses into the alveolar ducts and sacs. The respiratory bronchus is characterized by the presence of alveoli arising from its walls, indicating the start of the gas exchange process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Alveolar sac:</strong> Alveolar sacs are the terminal ends of the respiratory tree where clusters of alveoli are found. They are not the initial structures for gas exchange but are rather the sites where the alveoli are grouped.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Terminal bronchiole:</strong> Terminal bronchioles are the last part of the conducting zone and do not participate in gas exchange. They are lined with simple cuboidal epithelium without the presence of alveoli in their walls.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Intrapulmonary bronchiole:</strong> Intrapulmonary bronchioles refer to the bronchioles within the lung tissue that are part of the conducting zone and do not participate directly in gas exchange.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The respiratory bronchus is the structure where gas exchange begins in the lung, identified by its simple cuboidal epithelium and the presence of alveoli arising from its walls.</span></p>",
    "correct_choice_id": 203710,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00126 Mid Day Module (Pyqs, Mixed Bag-23)';
        const quizFilename = '00126-mid-day-module-pyqs-mixed-bag-23-965f6aab.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>